- 暂无数据
简体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
With the rapid development of technology, airborne LiDAR technology has become one of the key technologies in modern surveying, remote sensing, navigation and other fields. As an important component of this technology, the airborne LiDAR calibration board plays a crucial role in ensuring the accuracy and stability of the radar system. This article will explore the application and importance of air...
Zhang Jun, an academician team of Beijing University of Technology, pioneered the on chip spectral multiplexing perception architecture, and independently developed the first 100 channel megapixel hyperspectral real-time imaging device in the world, creating the world's highest light energy utilization rate. On November 7, the team's relevant achievements were published in the journal Nature, and ...
It is reported that researchers from the University of Waterloo in Canada have reported a study on the plasticity of copper oxide nanowires induced by femtosecond laser. The related research was published in Applied Surface Science under the title "Femtosecond laser induced plasticity in CuO nanowires".Metal oxide nanowires are ideal materials for manufacturing nanodevices, especially strain senso...
Photoacoustic technology provides a non-invasive method for detecting biological tissues, but its clinical application is limited, partly due to the large volume and high cost of laser sources. A compact PA sensing instrument powered by laser diodes for biomedical tissue diagnosis can provide clinical doctors with a practical and effective tool for evaluating breast diseases.By providing a cost-ef...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...